| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.46 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.45 | 0.007 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.38 | 0.07 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.37 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.34 | 0.09 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |